About this event

  • Date and time Wed 1 Sep 2021 from 2:30pm to 4 Sep 2021 at 12:30pm
  • Location Online
  • Organised by Vascular, Lipid and Metabolic Medicine Section, The European Society of Vascular Medicine

This free 4-day virtual conference will provide evidence-based lectures from highly respected international experts on best practice for the peripheral vascular disease (PVD) patient, along with a comprehensive review of PVD aspects, covering peripheral artery disease, venous disease and lymphology. And update on the latest evidence in epidemiology, diagnosis and management.

The extensive 4-day programme featuring eminent international speakers will cover: 

  • The latest advances in:
    • vascular and metabolic medicine
    • the management of hypercholesterolemia
  • Best current practice and/or current best evidence-based practice in:
    • the prevention and treatment of venous thromboembolic disease
    • peripheral arterial disease
    • Raynauds phenomenon
    • the prevention and treatment of lipid-lowering in peripheral arterial disease
    • Lymphatic disease
  • Best current use of antithrombotics in peripheral vascular disease
  • The impact of COVID-19 on microcirculation disorders
  • Current challenges in revascularisation

This is a unique multidisciplinary virtual conference providing education for physicians, surgeons and interventional radiologists. 

CPD learning accredited for all 4 days. 

This meeting has been partially supported by Bristol Myers Squibb in the form of an educational grant. We would also like to thank our sponsors Amgen, Bayer (Schweiz) AG, BIOTRONIK UK Ltd, Boston Scientific, Medi Ireland (Royale Distributing Agency Ltd), Sigvaris AG, Thuasne and Viatris for their support of this meeting.

Please note that none of the companies listed above have had any influence or involvement over the scientific programme, organisation or content of this meeting.

Join in the conversation online using #RSMVascular
Follow us on Twitter: @RoySocMed@_ESVM

Key speakers

Professor Gerry Fowkes

Emeritus Professor of Epidemiology, Usher Institute, College of Medicine and Veterinary Medicine, UK

Dr Fredrick Wigley

Physician-Scientist and Director, The Johns Hopkins Scleroderma Center, USA

Dr Marianne Brodmann

Head of Division of Angiology and Head of Clinical Research, Division of Angiology, Medical University of Graz, Austria

Professor Alberico Catapano

Professor of Pharmacology and Director, Center of Epidemiology and Preventive Pharmacology, University of Milan, the Laboratory of Lipoproteins, Immunity and Atherosclerosis, the Center for the Study of Atherosclerosis, Bassini Hospital, and Multimedica IRCCS Milan, Italy

Dr Sonia Anand

Professor of Medicine and Epidemiology, McMaster University, and Director of the Population Genomics Program and a vascular medicine specialist, Hamilton Health Services and McMaster University, Canada

Agenda

View the programme - Wednesday 1 September 2021 (UK time)

Symposium one: Introduction

Opening ceremony and welcome

Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, UK and Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine, UK

Symposium two: Debate - Vascular and metabolic medicine: Where are we going?

Chaired by: Professor Gerit-Holger Schernthaner, Austria

Discussion one

Professor Christian Heiss, Professor of Cardiovascular Medicine, University of Surrey, UK

Discussion two

Professor Andrew J Krentz, Visiting Professor, School of Population Health Sciences, University College London, UK

Comfort break

Symposium three: Venous thrombo-embolic disease

Chaired by: Professor Adriana Visona, Italy and Dr Paul Flynn, UK

This session has been sponsored by Viatris. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.

Risk of venous thromboembolism in patients with COVID‐19

Professor Ay Cihan, Austria

VTE in pregnancy

Professor Manuel Monreal Bosch, Spain

VTE: Extended treatment

Professor Paolo Prandoni, Italy

Thrombolysis in the prevention of PTS

Associate Professor Niels Baekgaard, Denmark

Discussion

Symposium four: Young academy of the ESVM session

Chaired by: Dr Thomas Gary, Austria and Dr Daniel Swerdlow, UK

Thrombotic events after COVID 19 vaccination: pathophysiology and treatment options

Dr Thomas Gary, Austria

Risk factors management in vascular patients: An ICP model

Paola Bigolin, Italy

The importance of early diagnosis to improve outcome in diabetic feet

Dr Rumaisa Banatwalla, UK

Symposium five: Plenary - New frontiers in the management of hypercholesterolemia

Chaired by: Dr Dan-Mircea Olinic, Romania and Dr Jaimini Cegla, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust, UK

New frontiers in the management of hypercholesterolemia

Professor Alberto Zambon, Italy

Comfort break

Vascular, Lipid and Metabolic Medicine Section AGM

Members only 

Vascular, Lipid and Metabolic Medicine Section AGM

Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine, UK

Close of meeting
View the programme - Thursday 2 September 2021 (UK time)

Welcome and introduction

Symposium six: Aspects of peripheral arterial disease

Chaired by: Dr Dragan Vasic, Serbia and Professor Christian Heiss, Professor of Cardiovascular Medicine, University of Surrey, UK

The PAD iceberg: Epidemiology and under-diagnosis

Professor Gerry Fowkes, Emeritus Professor of Epidemiology, University of Edinburgh, UK

The current role of DCB (Still state of the Art?) in the treatment of lower limb peripheral artery disease

Dr Ralf Langhoff, Medical Director, Head of Department
Angiology/Vascular Medicine, Berlin, Germany

Exercise in Peripheral Arterial Disease

Professor Lucia Mazzolai

Peri-interventional care of PAD patients

Dr Ulrich Frank, Switzerland

Symposium seven - Plenary: Antithrombotics in PAD

Chaired by: Professor Karel Roztocil, Czech Republic and Dr Handrean Soran, Consultant Physician and Endocrinologist and Honorary Senior Lecturer, Manchester University Hospitals NHS Foundation Trust, UK

This session has been sponsored by Bayer (Schweiz) AG. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.

Antithrombotics in PAD

Professor Sonia Anand, Canada

Symposium eight - Plenary: Lecture under joint auspices of IUA/ESVM

Chaired by: Vinko Boc, Specialist of Cardiology and Vascular Medicine, Head of Catheter Laboratory Unit Department of Vascular Diseases University Clinical Centre Ljubljana, Slovenia, Professor Sean Caroll and Dr Pier Luigi Antignani, Director, Vascular Centre, Nuova Villa Claudia, Rome, Italy

Arterial atherothrombotic and venous thromboembolic disease - the same entity with two different faces

Professor Pavel Poredos, Slovenia

The pharmacological treatment of AAA: can it avoid progression ?

Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine, UK

Comfort break

Symposium nine: ESC Aorta and PAD W/G Session

Chaired by: Professor Lucia Mazzolai, Switzerland and Professor Gerard Stansby, UK

Should we screen for AAA ?

Professor Victor Aboyans, France

Endovascular or surgical repair ?

Dr Henrik Sillesen, Denmark

What follow up after a AAA intervention?

Professor Daniel Staub, Switzerland

Discussion
Comfort break

Vascular, Lipid and Metabolic Medicine Section Council Meeting

Council members only 

Vascular, Lipid and Metabolic Medicine Section Council Meeting
Close of meeting
View the programme - Friday 3 September 2021 (UK time)

Welcome and introduction

Symposium ten: Microcirculation

Chaired by: Professor Agata Stanek, Poland and Professor Faisel Khan, Professor of Cardiovascular Sciences, University of Dundee, UK

COVID-19 and the cardiovascular system

Professor Tomasz Guzik, UK

Endothelial dysfunction in COVID-19

Dr Andreas Flammer, Switzerland

Microcirculation in cardiometabolic disease

Professor Coen Stehouwer, Chair, Department of Internal Medicine
Maastricht University Medical Centre+, Maastricht, the Netherlands

Panel discussion

Symposium eleven - Plenary: Raynauds phenomenon

Chaired by: Professor Patrick Carpentier, France and Dr John Pauling, UK

Raynauds phenomenon

Professor Fred Wigley, USA

Comfort break

Symposium twelve: Diabetes and PAD/diabetic foot

Chaired by: Dr Zsolt Pecsvarady, Hungary and Professor Andrew J Krentz, Visiting Professor, School of Population Health Sciences, University College London, UK

Death rate after foot ulcer

Dr Matthew Young, UK

Stem cell therapies for diabetic wounds

Dr Shibashish Giri, Germany

Community based interventions

Dr Adrian Heald, UK and Dr George Dunn, UK

Inpatient management of diabetic foot disease

Professor Gerry Rayman, UK

Symposium thirteen - Plenary: Lipid lowering in PAD: An effective approach for treatment and prevention

Chaired by: Dr Caitriona Canning, Ireland and Dr Dimitri Mikhailidis, Reader and Honorary Consultant, Clinical Biochemistry, Royal Free Hospital, University College London, UK

Lipid lowering in PAD: An effective approach for treatment and prevention

Professor Alberico Catapano, Italy

This session has been sponsored by Amgen. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.

Comfort break

European Society for Vascular Medicine AGM

ESVM members only 

European Society for Vascular Medicine AGM

Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, Dr Sonia Arnand and Professor Isabelle Quéré

Close of meeting
View the programme - Saturday 4 September 2021 (UK time)

Welcome and introduction

Symposium fourteen: Honorary fellowship award

Chaired by Professor Anders Gottsater, Sweden and Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, UK

Diabetes and venous diseases - is there a link?

Professor Karel Roztocil, Czech Republic

Symposium fifteen: VLMM CV Symposium: Challenges in revascularisation

Chaired by: Professor Sigrid Nikol and Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine

When to revascularise acute DVT?

Associate Professor Oliver Schlager, Austria 

Challenges in Pelvic vein disease

Dr Michael Lichtenberg, Germany

The calcified lesion and atherectomy

Associate Professor Juraj Madaric, Head of Department of Angiology, National Institute
of Cardiovascular Diseases, Bratislava, Slovakia

Still 'endovascular first' for effective PAD treatment

Dr Marianne Brodmann, Austria

Panel discussion
Comfort break

Symposium sixteen: Lymphatic disease

Chaired by: Dr Dimakakos Evangelos, Head of the Vascular-Lymphology, European Teaching Center of UEMS for Angiology, Vascular Medicine 3rd University Inyernal Medicine Hospital ‘SOTIRIA’, Greece and Dr Uazman Alam, UK 

This session has been sponsored by Thuasne. Please note the scientific programme and content of the session has not be influenced in any way by the sponsor.

From an epidemiologic point of view: What is Lymphedema? How to understand the controversies around the definition

Professor Christine Moffatt, UK

From a clinical/classification point of view: What is Lymphedema? How to understand the controversies around the definition

Dr Kristiana Gordon, Consultant in Dermatology & Lymphovascular Medicine, St George’s University Hospitals NHS Foundation Trust, London, UK

New therapeutic options: Genetics in primary lymphoedema - Impact on management

Professor Miikka Vikkula, Belgium and Professor Isabelle Queré, France

New therapeutic options: Surgery in primary lymphoedema - Specific issues

Dr Francesco Boccardo, Italy

Compression: Concepts and innovation in Lymphology

Professor Isabelle Queré, France

Symposium seventeen: Closing ceremony and thanks

Closing ceremony and thanks

Professor Jill Belch Professor of Vascular Medicine, University of Dundee and President of the European Society of Vascular Medicine, Professor Saroj Das, President, Section of Vascular Lipid Metabolic Medicine, Royal Society of Medicine

Close of meeting

Location

Online

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 6 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member